Crawford Announces New Ad Policy Group, Defends FDA Court Interventions

An FDA intercenter coordinating group will oversee medical product advertising to ensure it is properly regulated, according to Acting Commissioner Lester Crawford, PhD/DVM

More from Archive

More from Medtech Insight